Search the Newsreel

Zhengye Biotechnology Holding Ltd (ZYBT) Earnings Forecast: Future EPS & Revenue Growth Estimates

This article provides an earnings forecast for Zhengye Biotechnology Holding Ltd (ZYBT), focusing on future EPS and revenue growth estimates. As of August 8, 2026, ZYBT's stock closed at $1.890 USD, down 9.57%, with a market cap of $89.57 million. The page includes an …

Hengdeli (03389.HK) issues profit warning; expects interim attributable loss to shareholders of no less than RMB 31 million, swinging from profit to loss year-on-year.

Baosheng Media Group Holdings Ltd (BAOS) Stock News Today

This article provides current stock information for Baosheng Media Group Holdings Ltd (BAOS), noting a recent price increase of 9.13%. It indicates that more news, earnings reports, analyst ratings, and key developments will be added soon. The page serves as a hub for financial …

Chenghe Acquisition III Ord Shs Class A (CHEC) Earnings Forecast: Future EPS & Revenue Growth Estimates

Hengdeli warns of interim loss as sales and investment income weaken

Zhengye International Sets August Board Meeting to Review Interim Results and Dividend

ZYBT Stock Whipsaws As Speculative Trading Dominates Tape

Zhengye Biotechnology Holding Limited (ZYBT) stock is experiencing extreme volatility due to speculative trading, with large price swings that disconnect from its underlying fundamentals. Despite manageable debt and significant assets, the company shows negative returns on invested capital, indicating it's destroying value. Traders are …

Sin Heng Chan Berhad Reports Production Results for the Month of July 2026

YuanShengTai Dairy Farm Flags Sharp Profit Jump on Milk and Beef Sales

Dida eyes road back to revenue growth under Tongcheng umbrella

China Shengmu Warns of Public Float Shortfall and Potential Delisting Risk

Zhengye Biotechnology Holding Limited Regains Compliance with Nasdaq Bid Price Requirement

Zhengye Biotechnology Holding Limited (Nasdaq: ZYBT) announced that it has regained compliance with Nasdaq's minimum bid price requirement of $1.00 per share. This comes after its Class A ordinary shares closed at or above $1.00 for 10 consecutive business days from July 20 to …

ZYBT Stock Whipsaws As Speculative Trading Frenzy Unwinds

Zhengye Biotechnology Holding Limited (ZYBT) stock experienced extreme volatility, whipsawing significantly due to speculative trading. After a massive 1,047% surge, the stock plunged by over 70% and continued to show significant premarket swings, indicating a classic boom-and-bust pattern driven by momentum rather than fundamentals. …

Tian Cheng Holdings Moves to Restructure Share Capital via EGM

Jiangsu Hengrui Board to Review Interim Results and Dividend in August

Heng Tai Consumables Updates Board Roles and Committee Structure

Is Toyota Motor (TSE:7203) Fully Priced On Strong Q1 Results And A New Buyback?

Prinx Chengshan Sets August Board Meeting to Approve Interim Results and Dividend Plan

Zhengye’s closing bid price met Nasdaq’s $1 floor for 10 business days

Chenghe Acquisition III swings to Q2 FY26 net income of $774,007

Chenghe Acquisition III reported a net income of $774,007 for Q2 FY26, a significant improvement from a net loss in the prior year. The company's trust account held $130 million, but management expressed doubt about its going concern status due to expected acquisition costs …

Chenghe Acquisition III Co. Revenue Breakdown – NASDAQ:CHECU

This article focuses on the revenue breakdown of Chenghe Acquisition III Co. (NASDAQ: CHECU), providing an overview of its financial data. It highlights sections for statements, statistics, dividends, earnings, and segments, indicating where users can find details on top segments and regional performance. The …

$Zhengye Biotechnology (ZYBT.US)$ Will there be another miracle?[Grin][Cool Guy]

The article poses a question about whether Zhengye Biotechnology (ZYBT.US) will experience another "miracle." It's a brief post from a user named "活的踏实 活的精彩" within the moomoo Community, indicating a discussion about the stock's future performance. The post itself is minimal, serving primarily as …

Zhengye Biotechnology Company Profile & Introduction

This document appears to be a company profile and introduction for Zhengye Biotechnology. Without further content, a detailed summary is not possible, but it likely outlines the company's operations, mission, and key offerings within the biotechnology sector.

Why Sheng Siong Group's (SGX:OV8) Earnings Are Better Than They Seem

Chenghe Acquisition III Co. 2Q 2026: Net income $774K, EPS $0.05— 10-Q Summary

Chenghe Acquisition III (NASDAQ: CHEC) Q2 update on trust income, liquidity

Chenghe Acquisition III Co. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026

Why Zhengye Biotechnology Holding (ZYBT) Stock Is Up Today

Hengdeli Sets August Board Meeting to Approve Interim Results and Consider Dividend

China Shengmu Adds Public Float Marker to Stock Name Amid Listing Risk

Price to earnings forward of Zhengye International Holdings Co., Ltd. – HKEX:3363

Toyota (TSE:7203) Stock Still Looks Reasonable After Profit Forecast Upgrade

Changan Minsheng Logistics Warns of Profit Drop Despite Higher Revenue

Beijing Jingcheng Expands Gas and Hydrogen Operations with New Singapore and Tianjin Units

Price to sales forward of Sin Heng Chan (Malaya) Bhd. – MYX:SHCHAN

China Shengmu Faces Delisting Risk After Public Float Falls Below HKEX Threshold